M&A Deal Summary

Takeda Acquires Nimbus Therapeutics - NDI-034858

On December 13, 2022, Takeda acquired life science company Nimbus Therapeutics - NDI-034858 from Nimbus Therapeutics

Acquisition Highlights
  • This is Takeda’s 17th transaction in the Life Science sector.
  • This is Takeda’s 12th transaction in the United States.
  • This is Takeda’s 4th transaction in Massachusetts.

M&A Deal Summary
Date 2022-12-13
Target Nimbus Therapeutics - NDI-034858
Sector Life Science
Buyer(s) Takeda
Sellers(s) Nimbus Therapeutics
Deal Type Divestiture

Target

Nimbus Therapeutics - NDI-034858

Cambridge, Massachusetts, United States
Nimbus Therapeutics's NDI-034858 is an oral, selective allosteric tyrosine kinase 2 (TYK2) inhibitor being evaluated for the treatment of multiple autoimmune diseases following successful recent Phase 2b results in psoriasis.

Search 201,429 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Takeda

Tokyo, Japan
Category Company
Founded 1781
Sector Life Science
Employees47,347
Revenue 4.03T JPY (2023)
DESCRIPTION
Takeda's corporate headquarters in Tokyo, Japan.
Takeda's corporate headquarters in Tokyo, Japan.

Takeda is a global biopharmaceutical organization committed to improving the health and well-being of people worldwide. Takeda is dedicated to addressing unmet medical needs through the development of innovative and transformative therapies. The Company's diverse portfolio encompasses a wide range of therapeutic areas, including oncology, gastroenterology, rare diseases, neuroscience, and vaccines. Takeda was originally established in 1781 and is based in Tokyo, Japan.

DEAL STATS #
Overall 18 of 18
Sector (Life Science) 17 of 17
Type (Divestiture) 3 of 3
State (Massachusetts) 4 of 4
Country (United States) 12 of 12
Year (2022) 3 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-12-13 Nimbus Lakshmi

Cambridge, Massachusetts, United States

Nimbus Lakshmi is a clinical-stage company that designs and develops breakthrough medicines. Nimbus Lakshmi is based in Cambridge, Massachusetts.

Buy -

Seller(S) 1

SELLER

Nimbus Therapeutics

Cambridge, Massachusetts, United States
Category Company
Founded 2009
Sector Life Science
DESCRIPTION

Nimbus Therapeutics is a biotechnology company pioneering the application of computational chemistry to design treatments for substantial and underserved human diseases. The company’s focus on metabolic diseases, cancer and immune-inflammatory disorders reflects the mechanistic relationship between these disorders, and Nimbus’ ability to rapidly tackle well validated targets as well as those that have proven intractable to the approaches taken by others in the pharmaceutical and biotechnology industry, resulting in medicines with high potency, selectivity and other desirable drug-like properties.

DEAL STATS #
Overall 3 of 3
Sector (Life Science) 3 of 3
Type (Divestiture) 3 of 3
State (Massachusetts) 2 of 2
Country (United States) 3 of 3
Year (2022) 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-12-13 Nimbus Lakshmi

Cambridge, Massachusetts, United States

Nimbus Lakshmi is a clinical-stage company that designs and develops breakthrough medicines. Nimbus Lakshmi is based in Cambridge, Massachusetts.

Sell -
Mergr

Product

Company

Legal